PSMAfore trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

PSMAfore trial

May 18, 2025, 05:14 | Drugs

Pluvicto (177Lu-PSMA-617): Uses in Cancer, Side Effects, Dosage, Expectations, and More

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used to treat advanced…

All: 1 Posts: 1 - 100

'

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

'

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

'

20 Posts Not to Miss from ASCO 2025

'

Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?

'

Robin Zon: The Official End of My Term as ASCO President

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023